[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 226-229

Título :	Inhibition of cyp2d6 activity by bupropion
Tipo de documento:	texto impreso
Autores:	Michael Kotlyar, Autor ; Lisa H. Brauer, Autor ; Timothy S. Tracy, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 226-229
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Bupropión, Citocromo P-450 CYP2D6, Inhibidores del citocromo P-450 CYP2D6, Dextrometorfano, Inhibidores de enzimas.
Resumen:	The purpose of this study was to assess the effect of bupropion on cytochrome P450 2D6 (CYP2D6) activity. Twenty-one subjects completed this repeated-measures study in which dextromethorphan (30-mg oral dose) was administered to smokers at baseline and after 17 days of treatment with either bupropion sustained-release (150 mg twice daily) or matching placebo.
Link:	./index.php?lvl=notice_display&id=30906

[artículo] Inhibition of cyp2d6 activity by bupropion [texto impreso] / Michael Kotlyar, Autor ; Lisa H. Brauer, Autor ; Timothy S. Tracy, Autor . - 2023 . - pp. 226-229.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 226-229

Palabras clave:	Bupropión, Citocromo P-450 CYP2D6, Inhibidores del citocromo P-450 CYP2D6, Dextrometorfano, Inhibidores de enzimas.
Resumen:	The purpose of this study was to assess the effect of bupropion on cytochrome P450 2D6 (CYP2D6) activity. Twenty-one subjects completed this repeated-measures study in which dextromethorphan (30-mg oral dose) was administered to smokers at baseline and after 17 days of treatment with either bupropion sustained-release (150 mg twice daily) or matching placebo.
Link:	./index.php?lvl=notice_display&id=30906